Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.
collagen
extracellular matrix
hyaluronan
metalloproteinases
proteoglycans
skin
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
02
2022
accepted:
11
04
2022
entrez:
16
5
2022
pubmed:
17
5
2022
medline:
17
5
2022
Statut:
epublish
Résumé
Basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), referred to as keratinocyte carcinomas, are skin cancer with the highest incidence. BCCs, rarely metastasize; whereas, though generally not characterized by high lethality, approximately 2-4% of primary cSCCs metastasize with patients exhibiting poor prognosis. The extracellular matrix (ECM) serves as a scaffold that provides structural and biological support to cells in all human tissues. The main components of the ECM, including fibrillar proteins, proteoglycans (PGs), glycosaminoglycans (GAGs), and adhesion proteins such as fibronectin, are secreted by the cells in a tissue-specific manner, critical for the proper function of each organ. The skin compartmentalization to the epidermis and dermis compartments is based on a basement membrane (BM), a highly specialized network of ECM proteins that separate and unify the two compartments. The stiffness and assembly of BM and tensile forces affect tumor progenitors' invasion at the stratified epithelium's stromal border. Likewise, the mechanical properties of the stroma, e.g., stiffness, are directly correlated to the pathogenesis of the keratinocyte carcinomas. Since the ECM is a pool for various growth factors, cytokines, and chemokines, its' intense remodeling in the aberrant cancer tissue milieu affects biological functions, such as angiogenesis, adhesion, proliferation, or cell motility by regulating specific signaling pathways. This review discusses the structural and functional modulations of the keratinocyte carcinoma microenvironment. Furthermore, we debate how ECM remodeling affects the pathogenesis of these skin cancers.
Identifiants
pubmed: 35572966
doi: 10.3389/fmed.2022.879500
pmc: PMC9100789
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
879500Informations de copyright
Copyright © 2022 Kavasi, Neagu, Constantin, Munteanu, Surcel, Tsatsakis, Tzanakakis and Nikitovic.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Mol Carcinog. 2010 Apr;49(4):363-73
pubmed: 20082322
J Histochem Cytochem. 2011 Oct;59(10):908-17
pubmed: 21832148
FEBS J. 2017 Jan;284(1):27-41
pubmed: 27790852
Int J Dermatol. 2020 Oct;59(10):1258-1263
pubmed: 32686125
Antioxidants (Basel). 2015 Mar 26;4(2):248-68
pubmed: 26783703
Biomolecules. 2021 Sep 06;11(9):
pubmed: 34572532
J Cell Sci. 2009 Jun 1;122(Pt 11):1788-99
pubmed: 19435799
Acta Pharm Sin B. 2021 Apr;11(4):941-960
pubmed: 33996408
Cancer Cell. 2015 Apr 13;27(4):450-61
pubmed: 25858804
EMBO J. 2010 Jul 7;29(13):2242-52
pubmed: 20526283
Mol Biol Rep. 2016 Oct;43(10):1027-33
pubmed: 27406386
J Invest Dermatol. 2009 Apr;129(4):1016-25
pubmed: 18843292
Chem Rev. 2006 Mar;106(3):818-39
pubmed: 16522010
J Biomed Opt. 2018 May;23(5):1-10
pubmed: 29752800
Epigenomics. 2015;7(6):1003-15
pubmed: 26479312
Nature. 2017 May 25;545(7655):495-499
pubmed: 28514441
Nanomaterials (Basel). 2021 Dec 27;12(1):
pubmed: 35010011
J Natl Cancer Inst. 2015 Oct 16;108(1):
pubmed: 26476432
IUBMB Life. 2013 Feb;65(2):134-43
pubmed: 23297089
Pathology. 2016 Feb;48(2):177-87
pubmed: 27020390
Arch Dermatol Res. 2013 Jan;305(1):35-47
pubmed: 22740085
Matrix Biol. 2017 Nov;63:1-10
pubmed: 28126522
Exp Dermatol. 2015 Aug;24(8):579-84
pubmed: 25877039
Healthcare (Basel). 2022 Feb 10;10(2):
pubmed: 35206956
Pathol Oncol Res. 2014 Apr;20(2):475-81
pubmed: 24357157
J Oral Pathol Med. 2018 May;47(5):460-467
pubmed: 28940738
Anticancer Res. 2018 Feb;38(2):771-778
pubmed: 29374701
Oncol Lett. 2018 Sep;16(3):4064-4072
pubmed: 30128029
Skin Res Technol. 2021 Mar;27(2):227-233
pubmed: 32696597
J Cutan Pathol. 1999 Sep;26(8):386-90
pubmed: 10551410
Dan Med J. 2017 Oct;64(10):
pubmed: 28975891
BMC Cancer. 2021 Jul 15;21(1):816
pubmed: 34266392
J Cutan Pathol. 2021 Mar;48(3):374-383
pubmed: 33010047
Pathol Res Pract. 2013 Nov;209(11):705-9
pubmed: 24011615
Front Cell Dev Biol. 2020 Feb 28;8:71
pubmed: 32185171
PLoS One. 2014 Apr 01;9(4):e93555
pubmed: 24691432
Phys Biol. 2012 Dec;9(6):065003
pubmed: 23196920
J Mol Histol. 2021 Jun;52(3):597-609
pubmed: 33884540
Cancer Discov. 2011 Jul;1(2):137-43
pubmed: 21984974
JAMA Dermatol. 2019 Mar 1;155(3):298-306
pubmed: 30484823
Virchows Arch. 2008 Jan;452(1):83-90
pubmed: 18034264
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
J Biomed Sci. 2014 Feb 05;21:12
pubmed: 24502696
Biochem Biophys Res Commun. 2019 May 14;512(4):647-652
pubmed: 30685091
Br J Dermatol. 2009 Jun;160(6):1251-7
pubmed: 19222463
Cancer Lett. 2018 Jan 1;412:224-235
pubmed: 29107105
J Immunol Res. 2018 Nov 12;2018:1061780
pubmed: 30539028
Oncogene. 2007 Apr 12;26(17):2491-501
pubmed: 17099730
Genes Dev. 2016 May 1;30(9):1002-19
pubmed: 27151975
Int J Biol Markers. 2016 Feb 29;31(1):e53-61
pubmed: 26391478
Curr Top Microbiol Immunol. 2011;350:17-37
pubmed: 21061197
Curr Drug Deliv. 2016;13(4):500-11
pubmed: 26549038
J Immunol. 2019 Jan 1;202(1):278-291
pubmed: 30530592
Dis Markers. 2021 Jul 10;2021:5592693
pubmed: 34336006
Clin Exp Dermatol. 2005 Nov;30(6):682-7
pubmed: 16197389
Cancers (Basel). 2015 Oct 14;7(4):2054-62
pubmed: 26473929
Biochem Pharmacol. 2020 Aug;178:114048
pubmed: 32446889
Exp Dermatol. 2016 May;25(5):348-54
pubmed: 26660139
Adv Cancer Res. 2014;123:319-49
pubmed: 25081535
J Cancer. 2013;4(1):66-83
pubmed: 23386906
Adv Exp Med Biol. 2017;996:27-40
pubmed: 29124688
Photochem Photobiol. 2016 Nov;92(6):816-825
pubmed: 27859308
Matrix Biol. 2015 May-Jul;44-46:184-90
pubmed: 25661772
Adv Exp Med Biol. 2020;1245:97-131
pubmed: 32266655
Anal Cell Pathol (Amst). 2021 Oct 15;2021:2328218
pubmed: 34692375
PLoS One. 2014 Feb 05;9(2):e87263
pubmed: 24505282
J Invest Dermatol. 1991 Feb;96(2):250-4
pubmed: 1991985
Cancer Epidemiol Biomarkers Prev. 2008 Dec;17(12):3551-7
pubmed: 19064570
Front Immunol. 2019 Apr 24;10:875
pubmed: 31068944
Exp Dermatol. 2019 Apr;28(4):464-471
pubmed: 29105155
Neoplasma. 2020 Mar;67(2):354-363
pubmed: 31986892
Adv Exp Med Biol. 2020;1226:123-142
pubmed: 32030681
J Cutan Pathol. 2001 Feb;28(2):83-9
pubmed: 11168756
Nat Rev Cancer. 2018 Dec;18(12):767-777
pubmed: 30420765
J Invest Dermatol. 2011 Jun;131(6):1322-30
pubmed: 21307877
J Cell Biol. 2007 Dec 17;179(6):1311-23
pubmed: 18086923
Cancer Prev Res (Phila). 2018 May;11(5):265-278
pubmed: 29437671
Nature. 2020 Sep;585(7825):433-439
pubmed: 32879493
Ann N Y Acad Sci. 2007 Sep;1110:233-47
pubmed: 17911438
Dev Dyn. 2018 Mar;247(3):368-381
pubmed: 28758355
Int J Mol Sci. 2016 Jun 02;17(6):
pubmed: 27271600
J Invest Dermatol. 2022 May;142(5):1478-1488.e9
pubmed: 34756877
N Engl J Med. 2018 Jul 26;379(4):363-374
pubmed: 30044931
Br J Dermatol. 2005 Apr;152(4):720-6
pubmed: 15840104
Curr Proteomics. 2013 Sep;10(3):202-217
pubmed: 24228023
Front Oncol. 2020 Mar 19;10:352
pubmed: 32266137
Exp Dermatol. 2018 Oct;27(10):1160-1165
pubmed: 30033544
Cells. 2020 Sep 29;9(10):
pubmed: 33003440
J Biol Chem. 2020 Apr 17;295(16):5427-5448
pubmed: 32165498
Biochim Biophys Acta. 2014 Aug;1840(8):2571-80
pubmed: 24631662
J Invest Dermatol. 2021 Apr;141(4S):1104-1110
pubmed: 33358021
Nat Commun. 2020 Oct 8;11(1):5079
pubmed: 33033234
PLoS One. 2017 Oct 5;12(10):e0185668
pubmed: 28982115
Histopathology. 2007 Dec;51(6):793-804
pubmed: 18042068
J Exp Clin Cancer Res. 2016 Jan 15;35:12
pubmed: 26769084
Nat Rev Immunol. 2010 Dec;10(12):826-37
pubmed: 21088683
Biochem Biophys Res Commun. 2019 Jul 5;514(4):1115-1121
pubmed: 31101337
Cell. 1995 Jan 13;80(1):83-93
pubmed: 7813021
Mod Pathol. 2008 Dec;21(12):1444-50
pubmed: 18931651
Appl Immunohistochem Mol Morphol. 2008 Oct;16(5):433-41
pubmed: 18633319
Bioorg Med Chem. 2018 Oct 1;26(18):5194-5203
pubmed: 30249497
In Vivo. 2020 May-Jun;34(3):1271-1275
pubmed: 32354918
Br J Dermatol. 1996 Mar;134(3):465-8
pubmed: 8731670
Biomolecules. 2021 Jun 17;11(6):
pubmed: 34204372
Lasers Surg Med. 2014 Dec;46(10):757-72
pubmed: 25345858
J Invest Dermatol. 1997 Aug;109(2):225-31
pubmed: 9242512
Toxicol Appl Pharmacol. 2019 Aug 15;377:114632
pubmed: 31226360
Oncol Lett. 2016 May;11(5):3019-3024
pubmed: 27123056
J Dermatol. 2006 Sep;33(9):609-15
pubmed: 16958805
PLoS One. 2017 Aug 22;12(8):e0183415
pubmed: 28829805
J Immunother Cancer. 2017 Mar 21;5:23
pubmed: 28344809
Biol Open. 2018 Nov 14;7(11):
pubmed: 30429154
Genome Med. 2020 Sep 28;12(1):83
pubmed: 32988398
Crit Rev Oncol Hematol. 2019 May;137:57-83
pubmed: 31014516
Int J Mol Med. 2005 Dec;16(6):1117-24
pubmed: 16273295
J Biol Chem. 1997 May 30;272(22):13997-4000
pubmed: 9206724
Rom J Morphol Embryol. 2020 Oct-Dec;61(4):1221-1226
pubmed: 34171070
Matrix Biol. 2015 Mar;42:11-55
pubmed: 25701227
Med Mol Morphol. 2019 Jun;52(2):99-105
pubmed: 30276677
Immunol Rev. 2008 Apr;222:328-40
pubmed: 18364012
Front Oncol. 2021 Sep 17;11:717606
pubmed: 34604053
Front Endocrinol (Lausanne). 2018 Mar 06;9:69
pubmed: 29559954
Food Chem Toxicol. 2017 Mar;101:128-138
pubmed: 28109952
Int J Surg Pathol. 2015 Feb;23(1):20-5
pubmed: 24984957
Front Immunol. 2015 May 13;6:224
pubmed: 26029210
Pharmacol Rev. 2009 Jun;61(2):198-223
pubmed: 19549927
Cells. 2020 Apr 26;9(5):
pubmed: 32357580
Mol Ther. 2018 Jan 3;26(1):17-30
pubmed: 29055623
J Cell Biol. 2012 Oct 15;199(2):193-7
pubmed: 23071148
Exp Mol Pathol. 2005 Oct;79(2):151-60
pubmed: 16004981
Arch Biochem Biophys. 2008 Mar 1;471(1):85-93
pubmed: 18158910